GlassScriptPhysician profile
Nyla S Squyres
NPI 1386639029
$569.95
in general payments reported to CMS, 2019-2025
9 companies · $42.45 in 2025
The $42.45 reported for 2025 was less than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.86 · 2020: $34.68 · 2021: $43.93 · 2022: $102 · 2023: $31.63 · 2024: $230 · 2025: $42.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $304.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fujifilm Sonosite, INC. | $186.32 | 2024 | Sonosite Lx |
| Janssen Pharmaceuticals, INC | $134.24 | 2019-2021 | |
| Pfizer INC. | $96.42 | 2021-2023 | |
| Kerecis Limited | $67.56 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Gilead Sciences, INC. | $21.13 | 2022 | |
| Urgo Medical North America, LLC | $18.56 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Csl Behring | $16.17 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $15.70 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $13.85 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nyla Squyres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.